BRAF V600E and RNF43 Co-mutations Predict Patient Outcomes with Targeted Therapies in Real-World Cases of Colorectal Cancer

por Quintanilha, Julia C F, Graf, Ryon P, Oxnard, Geoffrey R
Publicado 2023

Clinical and Genomic Factors Associated with Greater Tumor Mutational Burden in Prostate Cancer

por Hougen, Helen Y., Graf, Ryon P., Li, Gerald, Quintanilha, Julia C.F., Lin, Douglas I., Ross, Jeffrey S., Punnen, Sanoj, Mahal, Brandon A.
Publicado 2023

MKX-AS1 Gene Expression Associated with Variation in Drug Response to Oxaliplatin and Clinical Outcomes in Colorectal Cancer Patients

por Gonzalez, Ricardo D., Small, George W., Green, Adrian J., Akhtari, Farida S., Motsinger-Reif, Alison A., Quintanilha, Julia C. F., Havener, Tammy M., Reif, David M., McLeod, Howard L., Wiltshire, Tim
Publicado 2023

Tumor Mutational Burden in Real-World Patients With Pancreatic Cancer: Genomic Alterations and Predictive Value for Immune Checkpoint Inhibitor Effectiveness

por Quintanilha, Julia C.F., Storandt, Michael H., Graf, Ryon P., Li, Gerald, Keller, Rachel, Lin, Douglas I., Ross, Jeffrey S., Huang, Richard S.P., Schrock, Alexa B., Oxnard, Geoffrey R., Chakrabarti, Sakti, Mahipal, Amit
Publicado 2023

Comparative Effectiveness of Immune Checkpoint Inhibitors vs Chemotherapy in Patients With Metastatic Colorectal Cancer With Measures of Microsatellite Instability, Mismatch Repair...

por Quintanilha, Julia C. F., Graf, Ryon P., Fisher, Virginia A., Oxnard, Geoffrey R., Ellis, Haley, Panarelli, Nicole, Lin, Douglas I., Li, Gerald, Huang, Richard S. P., Ross, Jeffrey S., Myer, Parvathi A., Klempner, Samuel J.
Publicado 2023

RYK Gene Expression Associated with Drug Response Variation of Temozolomide and Clinical Outcomes in Glioma Patients

por Gonzalez, Ricardo D., Small, George W., Green, Adrian J., Akhtari, Farida S., Havener, Tammy M., Quintanilha, Julia C. F., Cipriani, Amber B., Reif, David M., McLeod, Howard L., Motsinger-Reif, Alison A., Wiltshire, Tim
Publicado 2023

MiR-3168, miR-6125, and miR-4718 as potential predictors of cisplatin-induced nephrotoxicity in patients with head and neck cancer

por Quintanilha, Julia C. F., Cursino, Maria A., Borges, Jessica B., Torso, Nadine G., Bastos, Larissa B., Oliveira, Juliana M., Cobaxo, Thiago S., Pincinato, Eder C., Hirata, Mario H., Geraldo, Murilo V., Lima, Carmen S. P., Moriel, Patricia
Publicado 2021

Can acetylcysteine ameliorate cisplatin‐induced toxicities and oxidative stress without decreasing antitumor efficacy? A randomized, double‐blind, placebo‐controlled trial involvin...

por Visacri, Marília B., Quintanilha, Júlia C. F., de Sousa, Vanessa M., Amaral, Laís S., de F. L. Ambrósio, Rosiane, Calonga, Luciane, Curi, Silvia F. B. B., de T. Leme, Mayra F., Chone, Carlos T., Altemani, João M. C., Mazzola, Priscila G., Malaguti, Carina, Vercesi, Aníbal E., Lima, Carmen S. P., Moriel, Patricia
Publicado 2019